Trials / Completed
CompletedNCT00398606
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
A Triple-Blind, Randomized, Active-Controlled, Parallel-Group, Multicenter Study to Evaluate and Compare the Efficacy and Tolerability of Alendronate Sodium With Calcium Supplementation in the Treatment of Osteoporosis in Postmenopausal Women
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 650 (planned)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see how well alendronate and calcium as compared to calcium alone increase bone density in postmenopausal women with osteoporosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0217, alendronate sodium / Duration of Treatment : 2 Years | |
| DRUG | Comparator : calcium carbonate /Duration of Treatment : 2 Years |
Timeline
- Start date
- 1995-04-01
- Primary completion
- 1998-02-01
- First posted
- 2006-11-14
- Last updated
- 2022-02-03
Source: ClinicalTrials.gov record NCT00398606. Inclusion in this directory is not an endorsement.